TEL
+ 86-21-6420 0566
Код каталога 80017671
CAS NO.103890-78-4
Чистота 99%
Номер MDLMFCD00865936
Молекулярная формулаC26H33NO6
Молекулярный вес 455.5433
Температура плавления: 174~175°С
| Аспект | Подробнее |
|---|---|
| Механизм действия | Lacidipine is a selective and potent calcium antagonist that primarily targets L-type calcium channels in vascular smooth muscle cells. By blocking these channels, it inhibits calcium influx, leading to vasodilation and reduced blood pressure. Additionally, it has antioxidant properties and may reduce atherosclerosis by inhibiting the formation of reactive oxygen species and inflammatory pathways. |
| Показания к применению | – Treatment of hypertension (high blood pressure) in adults.<br>- Potential use in slowing the progression of atherosclerosis.<br>- Investigated for its potential anti-tumor effects in cancer immunotherapy. |
| Фармакокинетика | –Поглощение: Rapidly absorbed from the gastrointestinal tract, with peak plasma concentrations reached within 30 to 150 minutes.<br>-Распределение: Highly lipophilic, with extensive first-pass metabolism in the liver.<br>-метаболизм: Metabolized by CYP3A4, with no active metabolites detected.<br>-экскреция: Approximately 70% excreted in feces and 30% in urine.<br>-Период полураспада: Average terminal half-life is 13 to 19 hours. |
| Побочные эффекты | – Common: Headache, flushing, ankle edema, dizziness, palpitations.<br>- Rare: Depression, tremor, syncope, hypotension, angioedema.<br>- Potential for increased blood alkaline phosphatase levels. |
| Противопоказания | – Hypersensitivity to lacidipine or any of its components.<br>- Severe hypotension.<br>- Acute myocardial infarction (within 1 month) without concurrent treatment with other antihypertensive agents. |
| Условия хранения | Store in a cool place, with the container tightly closed in a dry and well-ventilated area. Recommended storage temperature is 2 to 8 °C. |
| Особые соображения | – Monitor blood pressure regularly, especially at the start of treatment.<br>- Use with caution in patients with severe renal or hepatic impairment.<br>- May interact with other antihypertensive agents, CYP3A4 inhibitors, or inducers.<br>- Potential for QTc interval prolongation, though this is generally minimal.<br>- In cancer immunotherapy, lacidipine may be investigated for its ability to reprogram tryptophan metabolism and enhance T-cell activity |
Отказ от ответственности: приведенный выше контент предназначен только для справки и общения среди инсайдеров отрасли и не гарантирует его точность или полноту. Согласно соответствующим законам и правилам, а также правилам этого веб-сайта, подразделения или лица, которые покупают соответствующие товары, должны получить действительные квалификации и условия квалификации.
Фабрика и отгрузка
